Sushil K Mahata Selected Research

chromogranin A (344-364)

1/2022	Putative regulation of macrophage-mediated inflammation by catestatin.
1/2022	Gut microbiota transplantation drives the adoptive transfer of colonic genotype-phenotype characteristics between mice lacking catestatin and their wild type counterparts.
1/2022	The anti-inflammatory peptide Catestatin blocks chemotaxis.
1/2020	Catestatin improves insulin sensitivity by attenuating endoplasmic reticulum stress: In vivo and in silico validation.
11/2019	Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.
1/2018	Catestatin as a Target for Treatment of Inflammatory Diseases.
1/2018	Catestatin: A Master Regulator of Cardiovascular Functions.
1/2018	Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity.
1/2014	Obligatory role for endothelial heparan sulphate proteoglycans and caveolae internalization in catestatin-dependent eNOS activation.
1/2014	Catestatin increases the expression of anti-apoptotic and pro-angiogenetic factors in the post-ischemic hypertrophied heart of SHR.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sushil K Mahata Research Topics

Disease

41	Hypertension (High Blood Pressure) 01/2022 - 05/2005
19	Obesity 01/2022 - 09/2005
14	Insulin Resistance 10/2021 - 10/2009
11	Inflammation (Inflammations) 01/2022 - 01/2014
7	Essential Hypertension 01/2018 - 10/2002
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 11/2006
5	Pheochromocytoma 01/2022 - 06/2002
5	Heart Failure 12/2020 - 01/2016
5	Neoplasms (Cancer) 11/2019 - 01/2004
4	Ischemia 12/2020 - 11/2010
4	Body Weight (Weight, Body) 01/2020 - 01/2012
4	Type 2 Diabetes Mellitus (MODY) 01/2018 - 10/2002
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 11/2019
3	Weight Loss (Weight Reduction) 11/2021 - 09/2005
3	Reperfusion Injury 01/2018 - 11/2010
3	Infections 01/2017 - 06/2008
3	Infarction (Infarctions) 01/2014 - 11/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2013 - 02/2008
2	Fibrosis (Cirrhosis) 01/2022 - 01/2017
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2017
2	Myocardial Infarction 12/2020 - 11/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2020
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2019 - 01/2004
2	Hyperglycemia 01/2016 - 10/2014
2	Hypertrophy 01/2012 - 12/2008
2	Nephrosclerosis 01/2010 - 12/2009
1	Crohn Disease (Crohn's Disease) 01/2022
1	Ulcerative Colitis 01/2022
1	Colitis 01/2022
1	Thymoma (Thymic Carcinoma) 01/2022
1	Bites and Stings (Sting) 01/2022
1	Diabetes Mellitus 01/2021
1	COVID-19 01/2021
1	Maternal Obesity 01/2021
1	Fatty Liver 12/2020

Drug/Important Bio-Agent (IBA)

32	Chromogranin AIBA 01/2022 - 01/2004
26	chromogranin A (344-364)IBA 01/2022 - 01/2004
25	CatecholaminesIBA 01/2022 - 06/2002
23	Peptides (Polypeptides)IBA 01/2022 - 01/2004
10	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2008
10	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 10/2009
8	ChromograninsIBA 01/2013 - 01/2004
7	pancreastatinIBA 11/2019 - 10/2002
7	Adrenergic Agents (Adrenergic Drugs)IBA 10/2010 - 07/2005
6	Nicotine FDA Link 01/2021 - 04/2010
6	Insulin (Novolin)FDA Link 01/2020 - 10/2009
5	Phosphotransferases (Kinase)IBA 01/2022 - 01/2014
5	Hormones (Hormone)IBA 01/2022 - 05/2005
5	Chromogranin BIBA 04/2010 - 01/2004
4	Messenger RNA (mRNA)IBA 08/2015 - 06/2004
3	Antimicrobial PeptidesIBA 01/2022 - 06/2008
3	CytokinesIBA 01/2020 - 01/2016
3	NeuropeptidesIBA 09/2019 - 01/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 10/2009
3	LeptinIBA 01/2016 - 01/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2014 - 10/2010
2	CollagenIBA 01/2022 - 01/2012
2	Insulin ReceptorIBA 01/2022 - 05/2011
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 11/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022 - 01/2021
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 12/2020
2	GlycogenIBA 11/2021 - 10/2014
2	SteroidsIBA 01/2021 - 05/2005
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2020
2	Estrogen ReceptorsIBA 01/2020 - 01/2018
2	LipidsIBA 01/2018 - 10/2009
2	Pharmaceutical PreparationsIBA 01/2017 - 09/2013
2	AntibodiesIBA 11/2016 - 01/2004
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2014 - 04/2010
2	Secretin FDA Link 07/2011 - 05/2003
2	Transcription Factors (Transcription Factor)IBA 02/2010 - 07/2007
2	Peptide YYIBA 12/2009 - 11/2009
2	Secretogranin IIIBA 03/2008 - 07/2007
2	Amino Acids FDA Link 05/2007 - 01/2004
1	Bacterial DNAIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	Insulin Receptor Substrate ProteinsIBA 01/2022
1	omptin outer membrane protease (omptin)IBA 01/2022
1	InterferonsIBA 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	Glycogen Synthase (Synthase I)IBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2021
1	ATP Translocases Mitochondrial ADPIBA 10/2021
1	Claudin-2IBA 01/2021
1	Opioid Receptors (Opioid Receptor)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Beclin-1IBA 12/2020
1	Metalloproteases (Metalloproteinases)IBA 12/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2020
1	AMP-Activated Protein KinasesIBA 12/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	CotinineIBA 01/2020

Therapy/Procedure

2	Intraperitoneal Injections 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 09/2019 - 10/2012
2	Therapeutics 09/2013 - 01/2010
1	Fecal Microbiota Transplantation 01/2022